Treating cystic fibrosis
Additional therapy available to NHS.
A new triple therapy treatment will be available to cystic fibrosis patients on the NHS, following an agreement between the Scottish Government, NHS Scotland and the pharmaceutical company.
Kaftrio®, produced by Vertex Pharmaceuticals, is a medicine that tackles the underlying causes of the disease by helping the lungs work more effectively.
Health Secretary Jeane Freeman, yesterday said:
“Cystic fibrosis is an inherited condition, which tragically shortens lives and affects around 900 people in Scotland.
“I am therefore very pleased that a revised pricing agreement has been reached between NHS National Procurement and Vertex Pharmaceuticals, to ensure that Kaftrio®, can be made available for the treatment of cystic fibrosis through the NHS.
“This is a potentially transformational treatment for cystic fibrosis, and I am delighted that patients in Scotland will be among the first in Europe to benefit and lead longer, healthier lives.
“The deal, agreed ahead of a licence being granted by the European Medicines Agency, means that clinicians working in cystic fibrosis treatment centres, will be able to prescribe the medicine to patients whom they consider will benefit from their use as soon as the licence is granted, in the coming weeks.
“I hope that this news will be welcome to many people who live with cystic fibrosis, and also their families and friends.”
It is estimated that around 800 people with cystic fibrosis in Scotland should be suitable for treatment with the range of medicines that are now available.
The terms of the deal also mean that many patients with rare mutations, which fall outside of the scope of the European Medicines Agency’s current licensing considerations, will also be able to benefit from Kaftrio.
Latest News from
Expanding the national vaccination programme14/06/2021 12:05:00
Roll-out to include international students.
New services to help find cancer sooner14/06/2021 10:05:00
A new initiative to speed up cancer diagnosis and provide GPs with an alternative route to urgently refer patients has been launched.
Councillors' code of conduct revision: consultation analysis14/06/2021 08:05:00
Analysis of responses to the consultation on possible revisions to the Councillors’ Code of Conduct.
Ethical standards in public life - model code of conduct for board members: consultation analysis11/06/2021 15:05:00
An analysis of responses to the consultation on current proposals for a revised Model Code of Conduct for members of devolved public bodies.
Remobilising NHS dentists11/06/2021 12:05:00
£5 million to help meet safety standards and see more patients.
Get into Summer11/06/2021 10:05:00
Children and young people most impacted by Covid will be supported by £20 million to create opportunities to socialise, play and reconnect this summer.
Final Proposals for councillor numbers and wards for Argyll and Bute, Highland and North Ayrshire council areas submitted to Scottish Ministers11/06/2021 08:05:00
Boundaries Scotland has submitted its final proposals for councillor numbers and wards in Argyll and Bute, Highland and North Ayrshire council areas to Scottish Ministers.
Coronavirus (Scotland) (No.2) Act 2020: sixth report - responses to requests under the Freedom of Information (Scotland) Act 200210/06/2021 15:05:00
Report on the Scottish Ministers’ handling of requests for information under the Freedom of Information (Scotland) Act 2002 for the period from 27 March to 26 May 2021.
Coronavirus Acts: seventh report to Scottish Parliament10/06/2021 12:05:00
This is the Scottish Government's seventh report on the operation and status of the provisions of the coronavirus legislation.